<DOC>
	<DOCNO>NCT02547883</DOCNO>
	<brief_summary>In patient ≥ 75 year , evidence statin primary prevention associate decreased mortality recent US recommendation consider statin people 40 75 year . Moreover , statin associate numerous side effect impact quality life people represent high cost French healthcare system . The aim present study evaluate cost/effectiveness ratio , real life , statin cessation people ≥ 75 year treat primary prevention .</brief_summary>
	<brief_title>Statins In The Elderly</brief_title>
	<detailed_description>Statins primary prevention associate 1.2 % decrease absolute risk cardiovascular event large randomized study . Anyway , patient ≥ 75 year , impact statin mortality demonstrate large observational study show increased risk mortality people low cholesterol . Moreover , statin associate numerous side effect , particularly elderly include myalgia myositis , diabetes , cognitive disorder , fatigue loss energy physical activity , treatment interaction . At last , cost statin French national health insurance 800 million euro per year ( include around 200 million euros people ≥ 75 year ) . The benefit/risk ratio statin establish primary prevention people ≥ 75 year , lead numerous discordant expert advice since specific randomize trial conduct population . Thus , patient ≥ 75 year treat statin primary prevention , study strategy stop statin therapy . The comparison strategy represent group patient continue statin dose . Patients follow every three month , accord general recommendation , 36 month . Clinical event prospectively register</detailed_description>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>People age ≥ 75 year Treated statin least one year , primary prevention Having reply standardized questionnaire allow screen history cardiovascular event Consent form sign Life prognosis 6 month Patient know homozygous double heterozygous familial hypercholesterolemia Dementia</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Statins</keyword>
	<keyword>Elderly</keyword>
	<keyword>Mortality</keyword>
	<keyword>Quality life</keyword>
	<keyword>Randomized trial</keyword>
	<keyword>Cost effectiveness study</keyword>
</DOC>